Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tokuyama H, Sakamoto H, Fujita T, Nanasato M, Okayama H, Nishikura T, Kirigaya H, Nishida K, Ono K, Kimura T.
Obayashi Y, et al. Among authors: okayama h.
Eur Heart J Cardiovasc Pharmacother. 2024 Jan 29:pvae009. doi: 10.1093/ehjcvp/pvae009. Online ahead of print.
Eur Heart J Cardiovasc Pharmacother. 2024.
PMID: 38285607